GLP-1s and Gallbladder Problems: Why Women Face Higher Risk and Which Symptoms to Watch
Gallbladder problems are a listed risk of GLP-1 weight-loss drugs, and women already have higher odds of gallstones. Here is what the labels show, why fast weight loss matters, and the symptoms that shouldn't wait.
GLP-1 weight-loss drugs modestly raise the chance of gallbladder problems, mainly gallstones and gallbladder inflammation. The absolute numbers in the FDA labels are small, around 1 to 2 people in 100 for gallstones. Women matter here because, independent of any drug, women are more likely than men to develop gallstones, especially with higher estrogen levels from pregnancy, birth control pills or hormone therapy, and with obesity. Rapid weight loss is itself a known trigger. Knowing the symptoms, and which ones need same-day care, is the practical takeaway.
What the labels report
Both major GLP-1 weight-loss drugs list acute gallbladder disease in their Warnings and Precautions. The rates from their placebo-controlled weight-reduction trials:
| Event | Drug | Placebo | Label |
|---|---|---|---|
| Gallstones (cholelithiasis) | 1.6% | 0.7% | Wegovy injection |
| Gallstones (cholelithiasis) | 2.5% | 1% | Wegovy tablets |
| Gallbladder inflammation (cholecystitis) | 0.6% | 0.2% | Wegovy injection |
| Gallstones (cholelithiasis) | 1.1% | 1% | Zepbound |
| Gallbladder inflammation (cholecystitis) | 0.7% | 0.2% | Zepbound |
| Gallbladder removal (cholecystectomy) | 0.2% | 0% | Zepbound |
Figures from the Wegovy prescribing information and the Zepbound prescribing information. Labels for both drugs advise that if gallbladder disease is suspected, gallbladder studies and appropriate follow-up are needed.
Two things the labels don't do: they don't break gallbladder events out by sex, and the trials weren't designed to show whether the risk differs for women. What we can say is that women begin with a higher baseline risk, which is the part of the title worth unpacking.
Why women start with higher risk
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) says gallstones affect 10 to 15 percent of the US population and that:
- Women are more likely to develop gallstones than men.
- Extra estrogen from pregnancy, hormone replacement therapy or birth control pills may make gallstones more likely.
- Obesity is a risk factor, especially in women.
- Fast weight loss, such as after bariatric surgery, raises the risk.
- Risk rises with age, and some groups, including American Indian and Mexican American people, have a higher risk.
Put those together and many women starting a GLP-1 have several risk factors at once: female, living with obesity, possibly on estrogen-containing contraception or menopausal hormone therapy, and about to lose weight quickly.
How weight loss leads to gallstones
Bile, made by the liver and stored in the gallbladder, carries cholesterol. When you lose weight quickly, the liver releases more cholesterol into bile. Eating less, and especially eating less fat, also means the gallbladder squeezes less often, so bile sits longer and can thicken. Cholesterol-rich, slow-moving bile is the setting in which most gallstones form. GLP-1 drugs reduce appetite and slow digestion, so both parts of that picture can apply. Researchers are still working out how much of the GLP-1 gallbladder signal comes from the weight loss and how much from the drug itself.
Symptoms to watch
A gallbladder attack
The NIDDK describes gallbladder attacks as usually causing pain in the upper right abdomen, sometimes lasting several hours. Many people also notice:
- Pain that can spread to the back or right shoulder blade.
- Pain that starts after a meal, especially a large or fatty one.
- Nausea or vomiting with the pain.
Many gallstones cause no symptoms at all and are found by chance on a scan.
Get care right away for
NIDDK lists these as reasons to see a doctor right away:
- Abdominal pain lasting several hours.
- Nausea and vomiting.
- Fever, even a low-grade one, or chills.
- Yellowing of the skin or the whites of the eyes (jaundice).
- Tea-colored urine and light-colored stools.
These can signal an infected gallbladder, a blocked bile duct or pancreatitis, all of which need prompt treatment.
The overlap problem: GI side effects vs gallbladder symptoms
Nausea, vomiting, indigestion and stomach pain are common GLP-1 side effects, especially in the first weeks and after dose increases. That overlap makes it easy to dismiss a gallbladder attack as "just the medication." These features point away from routine side effects and toward getting checked:
| More like a routine GI side effect | More like a gallbladder or pancreas problem |
|---|---|
| Queasiness or fullness, worse after big meals, easing over hours | Steady, severe pain in the upper right or middle abdomen lasting hours |
| Improves as your body adjusts over weeks | Comes in attacks, or gets worse over time |
| No fever | Fever or chills |
| Normal skin and eye color | Yellowing of skin or eyes, dark urine, pale stools |
| Can eat small meals | Pain going through to the back; can't keep anything down |
If you can't tell, call. Pain severe enough that you're wondering whether to go to urgent care is a reason to go. Our GLP-1 pill comparison and our semaglutide and tirzepatide profiles list the other warnings on these drugs.
Can you lower your risk?
Nobody can promise you won't get gallstones, but a few things are reasonable to discuss with your prescriber:
- Pace of weight loss. Rapid loss is the risk factor. If you're losing very quickly, ask whether that's what your prescriber intended.
- Don't skip meals entirely. Very low intake means the gallbladder rarely empties. Regular small meals that include some healthy fat keep it working.
- Gallbladder history. Tell your prescriber if you've had gallstones, gallbladder attacks or pancreatitis before.
- Estrogen. If you're on estrogen-containing birth control or hormone therapy, mention it. That's not a reason on its own to stop either, but it's part of your risk picture. Our HRT and peptides guide covers hormone therapy alongside other treatments.
- Medications for gallstone prevention. Some clinicians prescribe medicines to reduce gallstone formation during rapid weight loss, particularly after bariatric surgery. Whether that's appropriate on a GLP-1 is an individual decision for your clinician.
Tell your prescriber before starting if you have
- A history of gallstones, gallbladder attacks or gallbladder surgery.
- A history of pancreatitis.
- Current estrogen-containing contraception or menopausal hormone therapy.
- A current or planned pregnancy.
- A family history of gallbladder disease.
- Previous rapid weight loss that was followed by abdominal pain.
Compounded GLP-1s and the pills
The figures above come from FDA-approved products in controlled trials. Compounded semaglutide and tirzepatide are not FDA-approved and have no trial data of their own; since the active ingredient is meant to be the same and the weight loss works the same way, it's sensible to assume the same gallbladder risk applies. The newer GLP-1 pills carry gallbladder warnings too: the Wegovy tablets' rate (2.5% vs 1% on placebo) is in the table above, and Foundayo works through the same receptor and produces the same kind of weight loss. Products sold as "research use only" are not sold for human use and come with no label or safety data at all, which leaves you without even these baseline numbers. Our guide to compounded vs research vs prescribed peptides explains the differences.
If you already had your gallbladder removed
Gallbladder removal is common, and many women considering a GLP-1 have already had it. Without a gallbladder, gallstone attacks in the gallbladder itself are no longer possible, though stones can occasionally form in the bile ducts. Some people notice changes in how they tolerate fatty foods after removal, which can overlap with GLP-1 digestive side effects. Mention the surgery to your prescriber so both are factored in.
What happens if you get gallstones on a GLP-1
Your clinician will usually order an ultrasound and blood tests. Gallstones that cause no symptoms may simply be monitored. Symptomatic gallstones or an inflamed gallbladder are often treated by removing the gallbladder, which is a common operation. Whether to continue the GLP-1 afterward depends on your situation, the benefits you're getting and your clinician's judgment. Rapid weight loss links several GLP-1 side effects in women, including gallstones, hair shedding and muscle loss, so the pace of loss is worth discussing at every check-in; see GLP-1 hair shedding for another example.
Sources
- Novo Nordisk. Wegovy (semaglutide) prescribing information, Warnings and Precautions: acute gallbladder disease.
- Eli Lilly. Zepbound (tirzepatide) prescribing information, Warnings and Precautions: acute gallbladder disease.
- NIDDK. Definition and facts for gallstones.
- NIDDK. Symptoms and causes of gallstones.